• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脆弱老年人的膀胱过度活动症

Overactive bladder in the vulnerable elderly.

作者信息

Wolff Gillian F, Kuchel George A, Smith Phillip P

机构信息

Division of Urology, Department of Surgery, University of Connecticut Health Center, Farmington, CT, USA.

UConn Center on Aging, University of Connecticut Health Center, Farmington, CT, USA.

出版信息

Res Rep Urol. 2014 Oct 3;6:131-8. doi: 10.2147/RRU.S41843. eCollection 2014.

DOI:10.2147/RRU.S41843
PMID:25328867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4199655/
Abstract

Overactive bladder (OAB) is a common problem that may occur in individuals of all ages. It has a considerable impact on patient quality of life, and although moderately effective management strategies do exist, this condition often remains undiagnosed and untreated. OAB needs to be viewed as a symptom complex. Its presentation and management are complicated in the vulnerable elderly by the presence of baseline frailty and multiple coexisting chronic conditions. Furthermore, and beyond a simple understanding of symptomatology, providers must address patient goals and motivations as well as the expectations of caretakers. These multiple levels of perception, function, expectations, and treatment efficacy/risks must be tailored to the individual patient. While the vulnerable elderly patient may often have evidence of urinary tract dysfunction, OAB and urge urinary incontinence in this population must be understood as a multifactorial geriatric syndrome and viewed in the context of medical and functional baseline and precipitating risk factors. Expectations and goals must be tailored to the resources of vulnerable elderly patients and their caregivers, and care must be coordinated with other medical care providers. The management of OAB in the vulnerable elderly often poses significant management challenges. Nonetheless, with a thoughtful approach and an aim towards future research specifically for this population, significant reductions in morbidity and mortality long with enhancement in health-related quality of life are possible.

摘要

膀胱过度活动症(OAB)是一个常见问题,可能发生在所有年龄段的人群中。它对患者的生活质量有相当大的影响,尽管确实存在一些中度有效的管理策略,但这种情况往往仍未得到诊断和治疗。OAB需要被视为一种症状复合体。由于存在基线虚弱和多种并存的慢性病,其在脆弱的老年人中的表现和管理变得复杂。此外,除了简单了解症状学之外,医疗服务提供者还必须关注患者的目标和动机以及护理人员的期望。这些多层次的认知、功能、期望和治疗效果/风险必须针对个体患者进行调整。虽然脆弱的老年患者通常可能有尿路功能障碍的证据,但必须将该人群中的OAB和急迫性尿失禁理解为一种多因素的老年综合征,并结合医疗和功能基线以及诱发风险因素来考虑。期望和目标必须根据脆弱老年患者及其护理人员的资源进行调整,并且护理必须与其他医疗服务提供者进行协调。在脆弱的老年人中管理OAB往往带来重大的管理挑战。尽管如此,通过深思熟虑的方法以及针对该人群的未来研究目标,有可能大幅降低发病率和死亡率,并提高与健康相关的生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b4/4199655/98b51b8789a1/rru-6-131Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b4/4199655/98b51b8789a1/rru-6-131Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3b4/4199655/98b51b8789a1/rru-6-131Fig1.jpg

相似文献

1
Overactive bladder in the vulnerable elderly.脆弱老年人的膀胱过度活动症
Res Rep Urol. 2014 Oct 3;6:131-8. doi: 10.2147/RRU.S41843. eCollection 2014.
2
Economic impact of using fesoterodine for the treatment of overactive bladder with urge urinary incontinence in a vulnerable elderly population in the United States.在美国易损老年人群中使用非索罗定治疗伴急迫性尿失禁的膀胱过度活动症的经济影响。
J Med Econ. 2016;19(3):229-35. doi: 10.3111/13696998.2015.1111893. Epub 2015 Nov 23.
3
Vulnerable elderly patients and overactive bladder syndrome.脆弱的老年患者和膀胱过度活动症。
Drugs Aging. 2010 Sep 1;27(9):697-713. doi: 10.2165/11539020-000000000-00000.
4
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.索利那新用于治疗伴有尿失禁的膀胱过度活动症:症状困扰及与健康相关的生活质量结果
Ann Pharmacother. 2007 Mar;41(3):391-8. doi: 10.1345/aph.1H581. Epub 2007 Mar 6.
5
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.肉毒杆菌毒素 A 100U 显著改善伴有尿急和尿失禁的膀胱过度活动症患者的所有特发性膀胱过度活动症症状和生活质量:一项随机、双盲、安慰剂对照试验。
Eur Urol. 2013 Aug;64(2):249-56. doi: 10.1016/j.eururo.2013.04.001. Epub 2013 Apr 10.
6
Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients.非索罗定治疗老年患者膀胱过度活动症和急迫性尿失禁的疗效及安全性综述。
Drugs Aging. 2015 Feb;32(2):103-25. doi: 10.1007/s40266-014-0237-6.
7
Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.富马酸非索罗定 8 毫克优于 4 毫克,可减少膀胱过度活动症患者的急迫性尿失禁发作:随机、双盲、安慰剂对照的 EIGHT 试验结果。
BJU Int. 2014 Sep;114(3):418-26. doi: 10.1111/bju.12678. Epub 2014 Jul 1.
8
Correlation between psychological stress levels and the severity of overactive bladder symptoms.心理压力水平与膀胱过度活动症症状严重程度之间的相关性。
BMC Urol. 2015 Mar 8;15:14. doi: 10.1186/s12894-015-0009-6.
9
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.托特罗定缓释片对患有膀胱过度活动症和急迫性尿失禁的性活跃女性患者报告结局的影响。
Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.
10
Treatments for overactive bladder: focus on pharmacotherapy.膀胱过度活动症的治疗:聚焦药物治疗。
J Obstet Gynaecol Can. 2012 Nov;34(11):1092-1101. doi: 10.1016/S1701-2163(16)35440-8.

引用本文的文献

1
Polychlorinated biphenyl (PCB) exposure in adult female mice can influence bladder contractility.成年雌性小鼠接触多氯联苯(PCB)会影响膀胱收缩力。
Am J Clin Exp Urol. 2023 Oct 15;11(5):367-384. eCollection 2023.
2
Personalised 3D-Printed Mucoadhesive Gastroretentive Hydrophilic Matrices for Managing Overactive Bladder (OAB).用于治疗膀胱过度活动症(OAB)的个性化3D打印粘膜粘附胃滞留亲水性基质
Pharmaceuticals (Basel). 2023 Feb 28;16(3):372. doi: 10.3390/ph16030372.
3
Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder.

本文引用的文献

1
The efficacy and tolerability of the β3-adrenoceptor agonist mirabegron for the treatment of symptoms of overactive bladder in older patients.β3肾上腺素能受体激动剂米拉贝隆治疗老年患者膀胱过度活动症症状的疗效和耐受性。
Age Ageing. 2014 Sep;43(5):666-75. doi: 10.1093/ageing/afu017. Epub 2014 Mar 6.
2
Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects.关于中枢神经系统和心血管系统副作用,抗胆碱能药物用于治疗膀胱过度活动症的原理。
Korean J Urol. 2013 Dec;54(12):806-15. doi: 10.4111/kju.2013.54.12.806. Epub 2013 Dec 10.
3
非索罗定在老年膀胱过度活动症患者中的安全性和耐受性
Can Geriatr J. 2022 Mar 2;25(1):72-78. doi: 10.5770/cgj.25.530. eCollection 2022 Mar.
4
A non-interventional cross-sectional re-contact study investigating the relationship between overactive bladder and frailty in older adults in Japan.一项在日本进行的非介入性、横断面再联系研究,旨在调查老年人群中膀胱过度活动症与虚弱之间的关系。
BMC Geriatr. 2022 Jan 21;22(1):68. doi: 10.1186/s12877-022-02756-7.
5
Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting.非干预性环境下膀胱过度活动症患者初始剂量决策、丙哌维林滴定增量及治疗结果的相关因素
J Clin Med. 2021 Jan 15;10(2):311. doi: 10.3390/jcm10020311.
6
Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR).米拉贝隆对老年膀胱过度活动症患者认知功能的影响:一项 4 期随机、安慰剂对照研究(PILLAR)的 MoCA 结果。
BMC Geriatr. 2020 Mar 18;20(1):109. doi: 10.1186/s12877-020-1474-7.
7
ELECtric Tibial nerve stimulation to Reduce Incontinence in Care homes: protocol for the ELECTRIC randomised trial.电刺激胫神经以减少养老院失禁:ELECTRIC随机试验方案
Trials. 2019 Dec 16;20(1):723. doi: 10.1186/s13063-019-3723-7.
8
[Do benign prostatic hyperplasia drugs affect mood or cognition?].[良性前列腺增生药物会影响情绪或认知吗?]
Urologe A. 2019 Mar;58(3):248-253. doi: 10.1007/s00120-019-0871-z.
9
The Aging Overactive Bladder: A Review of Aging-Related Changes from the Brain to the Bladder.衰老的膀胱过度活动症:从大脑到膀胱的衰老相关变化综述
Curr Bladder Dysfunct Rep. 2017 Mar;12(1):42-47. doi: 10.1007/s11884-017-0406-7. Epub 2017 Feb 6.
10
Overactive Bladder Is Strongly Associated With Frailty in Older Individuals.膀胱过度活动症与老年人身体虚弱密切相关。
Urology. 2017 Aug;106:26-31. doi: 10.1016/j.urology.2017.03.058. Epub 2017 May 11.
Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly.
膀胱过度活动症是一种脑部疾病吗?脑白质在老年人中的病理生理作用。
Int J Urol. 2014 Jan;21(1):33-8. doi: 10.1111/iju.12288. Epub 2013 Sep 30.
4
Mirabegron for overactive bladder: a novel, first-in-class β3-agonist therapy.米拉贝隆用于治疗膀胱过度活动症:一种新型的、同类首创的β3受体激动剂疗法。
Urol J. 2013 Sep 26;10(3):935-40.
5
Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial.急迫性尿失禁脆弱老年患者中非索罗定的疗效:一项双盲、安慰剂对照试验。
J Urol. 2014 Feb;191(2):395-404. doi: 10.1016/j.juro.2013.08.027. Epub 2013 Aug 21.
6
Dimensions of sensation assessed in urinary urgency: a systematic review.急迫性尿失禁的感觉维度评估:系统综述。
J Urol. 2013 Oct;190(4):1165-72. doi: 10.1016/j.juro.2013.04.076. Epub 2013 Apr 30.
7
Improving the health care of geriatric patients: management of urinary incontinence: a position paper.改善老年患者的医疗保健:尿失禁的管理:一份立场文件。
Z Gerontol Geriatr. 2013 Jul;46(5):456-64. doi: 10.1007/s00391-013-0491-y.
8
Effect of renal or hepatic impairment on the pharmacokinetics of mirabegron.美贝维林在肾功能或肝功能损害患者中的药代动力学变化。
Clin Drug Investig. 2013 Jan;33(1):11-23. doi: 10.1007/s40261-012-0031-3.
9
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.成人过度活动膀胱(非神经原性)的诊断和治疗:AUA/SUFU 指南。
J Urol. 2012 Dec;188(6 Suppl):2455-63. doi: 10.1016/j.juro.2012.09.079. Epub 2012 Oct 24.
10
EAU guidelines on assessment and nonsurgical management of urinary incontinence.EAU 指南:尿失禁的评估和非手术治疗。
Eur Urol. 2012 Dec;62(6):1130-42. doi: 10.1016/j.eururo.2012.08.047. Epub 2012 Aug 31.